Craig A. Portell

ScholarGPS® ID: 83401820482686

Affiliation

University of Virginia, Charlottesville, United States

Affiliation History

Field

Medicine

Discipline

Hematology

Top Specialties

Metrics Summary

Publication Count

Predicted Citations

1,810

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Brentuximab vedotin in combination with lenalidomide and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma: Results from the phase 3 ECHELON-3 study. (journal article) Kim, Jeong A \| Hahn, Uwe \| Kim, Won-Seog \| Fleury, Isabelle \| Laribi, Kamel \| Bergua Burgues, Juan Miguel \| Bouabdallah, Krimo \| Forward, Nick \| Bijou, Fontanet \| MacDonald, David \| ... \| Bartlett, Nancy L. Journal of Clinical Oncology, volume 42, issue 17_suppl, pages LBA7005-LBA7005 (2024). 10.1200/JCO.2024.42.17_suppl.LBA7005 Cited by (1) \| Cite \| Source
A retrospective observational study of rapid titration of venetoclax (VEN) in patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). (journal article) Babalola, Tijesuni \| Ayers, Emily C. \| Douvas, Michael G. \| Foster, Laahn \| Densmore, John \| Williams, Michael E. \| Portell, Craig Anthony Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e19018-e19018 (2024). 10.1200/JCO.2024.42.16_suppl.e19018 Cite \| Source
Applications of the partial-order continual reassessment method in the early development of treatment combinations (journal article) Wages, Nolan A \| Dillon, Patrick M \| Portell, Craig A \| Slingluff, Craig L \| Petroni, Gina R Clinical Trials, volume 21, issue 3, pages 331-339 (2024). 10.1177/17407745241234634 Cite \| Source
Overall Survival Following First and Second Relapse of DLBCL Treated with Therapies Including Autologous Transplant and CAR-T Cells: Results from the Lion Prospective Observational Registry (journal article) Kirkpatrick, Greg \| Switchenko, Jeffrey M. \| Kives, Melissa \| Baird, Katelin \| Maddocks, Kami J. \| Romancik, Jason T. \| Stephens, Deborah M. \| Shah, Harsh \| Pinilla-Ibarz, Javier \| Chavez, Julio C \| ... \| Link, Brian K. Blood, volume 142, issue Supplement 1, pages 6325-6325 (2023). 10.1182/blood-2023-187198 Cite \| Source
Primary Analysis and Results of Bendamustine, Rituximab, and Venetoclax (BR-VEN) for Initial Treatment of Mantle Cell Lymphoma in Subjects over 60 Years of Age (PrE0405) (journal article) Portell, Craig A. \| Jegede, Opeyemi \| Bennani, N. Nora \| Naik, Seema \| Reynolds, Christopher M. \| Patel, Priyank P. \| Robertson, Michael J. \| Kahl, Brad S. Blood, volume 142, issue Supplement 1, pages 733-733 (2023). 10.1182/blood-2023-182374 Cite \| Source
Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us? (journal article) Lantz, Jeffrey \| Portell, Craig A. \| Ayers, Emily C. Blood Reviews, volume 61 (2023). 10.1016/j.blre.2023.101101 Cited by (1) \| Cite \| Source
In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasms (journal article) Ayers, Emily \| Canderan, Glenda \| Williams, Michael E. \| Keshavarz, Behnam \| Portell, Craig A. \| Wilson, Jeffrey M. \| Woodfolk, Judith A. Blood Cancer Journal, volume 13, issue 1 (2023). 10.1038/s41408-023-00884-w Cite \| Source
PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis (journal article) Jayappa, Kallesh D. \| Tran, Brian \| Gordon, Vicki L. \| Morris, Christopher \| Saha, Shekhar \| Farrington, Caroline C. \| O’Connor, Caitlin M. \| Zawacki, Kaitlin P. \| Isaac, Krista M. \| Kester, Mark \| ... \| Narla, Goutham Journal of Clinical Investigation, volume 133, issue 13 (2023). 10.1172/JCI155938 Cited by (4) \| Cite \| Source
Pembrolizumab in combination with epigenetic therapy is safe and active in heavily treated patients with peripheral T‐cell lymphoma and cutaneous T‐cell lymphoma (journal article) Roberts, N. L. \| Lister, J. \| Benani, N. N. \| Jain, S. \| Battaglia, T. \| Abdelmalek, M. \| Ayers, E. C. \| Portell, C. \| Williams, M. E. \| Batchala, P. \| ... \| Marchi, E. Hematological Oncology, volume 41, issue S2, pages 269-270 (2023). 10.1002/hon.3164_181 Cite \| Source
Weight Change Trends and Impact of Body Mass Index (BMI) on Outcomes in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma, a Retrospective Analysis from the Lymphoma Innovations Orien Network (LION) Consortium (journal article) Sawalha, Yazeed \| Du, Chenxi \| Switchenko, Jeffrey M. \| Kives, Melissa \| Churchman, Michelle L. \| Stephens, Deborah M. \| Pinilla Ibarz, Javier \| Evens, Andrew Matthew \| Maddocks, Kami J. \| Link, Brian K. \| ... \| Portell, Craig A. Blood, volume 140, issue Supplement 1, pages 11956-11958 (2022). 10.1182/blood-2022-163681 Cite \| Source
Nanoliposomal C6-Ceramide Exhibits Synergistic Anti-Cancer Activity with a Small Molecule Agonist of PP2A in Chronic Lymphocytic Leukemia (journal article) Jayappa, Kallesh D. \| Vass, Luke R. \| Farrington, Caroline \| Illendula, Anuradha \| Walker, Susan \| Williams, Michael E. \| Portell, Craig A. \| Fox, Todd \| Narla, Goutham \| Kester, Mark Blood, volume 140, issue Supplement 1, pages 7816-7817 (2022). 10.1182/blood-2022-168086 Cited by (1) \| Cite \| Source
Ibrutinib and Ixazomib in Relapsed/Refractory Mantle Cell Lymphoma: Precog 0404 (journal article) Cohen, Jonathon B. \| Jegede, Opeyemi \| Portell, Craig A. \| Hamadani, Mehdi \| Diefenbach, Catherine S. \| David, Kevin A. \| Fletcher, Christopher D. \| Landsburg, Daniel J. \| Mantha, Suparna \| Kahl, Brad S. Blood, volume 140, issue Supplement 1, pages 6487-6488 (2022). 10.1182/blood-2022-164710 Cite \| Source
Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry (journal article) Bond, David A. \| Romancik, Jason T. \| Switchenko, Jeffrey M. \| Berkowitz, Brielle \| Day, Jonathan R \| Farooq, Umar \| Ayyappan, Sabarish \| Baird, Katelin \| Churchman, Michelle L. \| Evens, Andrew M. \| ... \| Stephens, Deborah M. Blood, volume 140, issue Supplement 1, pages 6509-6511 (2022). 10.1182/blood-2022-160306 Cite \| Source
Pembrolizumab in Combination with Epigenetic Therapy Is Safe and Active in Heavily Treated Patients with Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL): Preliminary Results from the Embolden Trial (journal article) Roberts, Nathan \| Lister, John \| Bennani, N. Nora \| Jain, Salvia \| Battaglia, Tammy \| Ayers, Emily C. \| Portell, Craig A. \| Williams, Michael E. \| Batchala, Prem \| Pal, Ipsita \| ... \| Marchi, Enrica Blood, volume 140, issue Supplement 1, pages 9425-9426 (2022). 10.1182/blood-2022-170181 Cited by (2) \| Cite \| Source
CNS prophylaxis in DLBCL: first do no harm (journal article) Portell, Craig A. Blood, volume 139, issue 16, pages 2420-2421 (2022). 10.1182/blood.2022015432 Cited by (1) \| Cite \| Source
Safety and Anti-Tumor Activity of Plamotamab (XmAb13676), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Subjects with Relapsed/Refractory Non-Hodgkin's Lymphoma (journal article) Patel, Krish \| Michot, Jean-Marie \| Chanan-Khan, Asher \| Ghesquieres, Herve \| Bouabdallah, Kamal \| Byrd, John C. \| Cartron, Guillaume \| Portell, Craig A. \| Solh, Melhem \| Tilly, Hervé \| ... \| Phillips, Tycel Blood, volume 138, issue Supplement 1, pages 2494-2494 (2021). 10.1182/blood-2021-144350 Cited by (19) \| Cite \| Source
Phase II Study of Venetoclax in Combination with Obinutuzumab and Bendamustine in Patients with High Tumor Burden Follicular Lymphoma As Front Line Therapy (PrECOG 0403) (journal article) Portell, Craig A. \| Jegede, Opeyemi \| Wagner-Johnston, Nina D. \| Nowakowski, Grzegorz S. \| Fletcher, Christopher D. \| Cohen, Jonathon B. \| David, Kevin A. \| Khan, Nadia \| Rosenstein, Lori J \| Kahl, Brad S. Blood, volume 138, issue Supplement 1, pages 814-814 (2021). 10.1182/blood-2021-145217 Cited by (5) \| Cite \| Source
Antibody and T-Cell Responses to Covid-19 mRNA Vaccines in Patients with B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CLL) (journal article) Ayers, Emily C. \| Wilson, Jeffrey \| Canderan, Glenda \| Keshavarz, Behnam \| Woodfolk, Judith \| Portell, Craig A. \| Williams, Michael E. Blood, volume 138, issue Supplement 1, pages 1335-1335 (2021). 10.1182/blood-2021-146165 Cited by (2) \| Cite \| Source
Outcomes of Primary Bone Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Multicenter Retrospective Analysis (journal article) Rezazadeh, Alexandra \| Szabo, Aniko \| Monahan, Kathleen \| Khurana, Arushi \| Inwards, David J. \| Lunning, Matthew A. \| Cashen, Amanda \| Bartlett, Nancy L. \| Caimi, Paolo F. \| Rodgers, Thomas D. \| ... \| Fenske, Timothy S. Blood, volume 138, issue Supplement 1, pages 1451-1451 (2021). 10.1182/blood-2021-145145 Cite \| Source
Dose Finding Study of Ibrutinib and Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma (journal article) Portell, Craig A \| Wages, Nolan A \| Kahl, Brad S. \| Budde, Lihua E \| Chen, Robert W \| Cohen, Jonathon B \| Varhegyi, Nikole E \| Petroni, Gina R \| Williams, Michael E Blood Advances (2021). 10.1182/bloodadvances.2021005357 Cited by (7) \| Cite \| Source